ArticleDiagnostics (Basel, Switzerland)2022

Precision Medicine in Breast Cancer: Do MRI Biomarkers Identify Patients Who Truly Benefit from the Oncotype DX Recurrence Score

Francesca Galati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.